Articles scientifiques

Complications of mesh repair in hiatal surgery: about 3 cases and review of the literature.

Auteurs : De Moor V, Zalcman M, Delhaye M, El Nakadi I
Année : 2012
Journal : Surg Laparosc Endosc Percutan Tech
Volume : 22(4)
Pages : e222-5

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.

Auteurs : Baselga J, Bradbury I, Eidtmann H, Di Cosimo S, de Azambuja E, Aura C, Gómez H, Dinh P, Fauria K, van Dooren V, Aktan G, Goldhirsch A, Chang TW, Horváth Z, Coccia-Portugal M, Domont J, Tseng LM, Kunz G, Sohn JH, Semiglazov V, Lerzo G, Palacova M, Probachai V, Pusztai L, Untch M, Gelber Rd, Piccart-Gebhart M
Année : 2012
Journal : Lancet
Volume : 379(9816)
Pages : 633-40

Targeted therapies in non-small cell lung cancer: which implication in routine practice.

Auteurs : Meert AP, Berghmans T
Année : 2012
Journal : Thoracic Surgery Bulletin of Turkish Thoracic Society
Volume : -
Pages : 167-172

Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines.

Auteurs : Curigliano G, Cardinale D, Suter T, Plataniotis G, de Azambuja E, Sandri MT, Criscitiello C, Goldhirsch A, Cipolla C, Roila F
Année : 2012
Journal : Ann Oncol
Volume : 23 Suppl 7
Pages : vii155-66

Patient information in stem cell transplantation from the perspective of health care professionals: A survey from the Nurses Group of the European Group for Blood and Marrow Transplantation.

Auteurs : Kirsch M, Crombez P, Calza S, Eeltink C, Johansson E
Année : 2012
Journal : Bone Marrow Transplant.
Volume : 47(8)
Pages : 1131-3

Minimal residual disease and circulating tumor cells in breast cancer: open questions for research.

Auteurs : Ignatiadis M, Sotiriou C, Pantel K
Année : 2012
Journal : Recent Results Cancer Res.
Volume : 195
Pages : 3-9

Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01).

Auteurs : Azim HA, Metzger-Filho O, de Azambuja E, Loibl S, Focant F, Gresko E, Arfi M, Piccart-Gebhart M
Année : 2012
Journal : Breast Cancer Res. Treat.
Volume : 133(1)
Pages : 387-91

Atypical presentation and localization of granulosa cell tumor-A case report and review of the literature

Auteurs : Sakkas GE, Bucella D, de Wind A, Stanciu C
Année : 2012
Journal : Open Journal of Obstetrics and Gynecology
Volume : 2(2)
Pages : 161-163

HDAC isoenzyme expression is deregulated in chronic lymphocytic leukemia B-cells and has a complex prognostic significance.

Auteurs : Van Damme M, Crompot E, Meuleman N, Mineur P, Bron D, Lagneaux L, Stamatopoulos B
Année : 2012
Journal : Epigenetics
Volume : 7(12)
Pages : 1403-1412

13th meeting on cancer-related emergencies and cancer-related severe complications].

Auteurs : Sculier JP
Année : 2012
Journal : Rev Med Brux
Volume : 33(6)
Pages : 562-3

Understanding the biology of triple-negative breast cancer.

Auteurs : Criscitiello C, Azim HA, Schouten PC, Linn SC, Sotiriou C
Année : 2012
Journal : Ann Oncol
Volume : 23 Suppl 6
Pages : vi13-vi18

Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.

Auteurs : Goris Gbenou M, Peltier A, Addla SK, Lemort M, Bollens R, Larsimont D, Roumeguère T, Schulman CC, Van Velthoven R
Année : 2012
Journal : Urol. Int.
Volume : 88(1)
Pages : 12-7

Dissecting the heterogeneity of triple-negative breast cancer.

Auteurs : Metzger-Filho O, Tutt A, de Azambuja E, Saini KS, Viale G, Loi S, Bradbury I, Bliss JM, Azim HA, Ellis P, Di Leo A, Baselga J, Sotiriou C, Piccart-Gebhart M
Année : 2012
Journal : J. Clin. Oncol.
Volume : 30(15)
Pages : 1879-87

la douleur est elle une norme universelle ?

Auteurs : Lossignol D
Année : 2012
Journal : Douleur analg.
Volume : 25
Pages : 186-192

Targeted therapies in breast cancer: are heart and vessels also being targeted?

Auteurs : Criscitiello C, Metzger-Filho O, Saini KS, de Castro G, Diaz M, La Gerche A, de Azambuja E, Piccart-Gebhart M
Année : 2012
Journal : Breast Cancer Res
Volume : 14(3)
Pages : 209

Expression profiling in: WHO Classification of Tumours of the Breast, (Chapter 1: Invasive Breast Carcinoma: introduction and general features) Chapter book : (IARC, 4th edition, 2012)

Auteurs : Van de Vijver MJ, Hayes D, Perou C, Sotiriou C, Reis LO
Année : 2012
Journal : Book
Volume : 4th edition
Pages : 29-31

AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell -based microenvironment: preclinical evidence for its association with chronic lymphocytic leukemia treatments.

Auteurs : Stamatopoulos B, Meuleman N, De Bruyn C, Pieters K, Mineur P, Le Roy C, Saint-Georges S, Varin-Blank N, Cymbalista F, Bron D, Lagneaux L
Année : 2012
Journal : Haematologica
Volume : 97(4)
Pages : 608-615

Dual human epidermal growth factor receptor 2 blockade: another step forward in treating patients with human epidermal growth factor receptor 2-positive breast cancer.

Auteurs : Zardavas D, Bozovic-Spasojevic I, de Azambuja E
Année : 2012
Journal : Curr Opin Oncol
Volume : 24(6)
Pages : 612-22

Safety and Efficacy of Radioimmunotherapy with 90Yttrium-rituximab in Patients with Relapsed CD20+ B cell Lymphoma: A Feasibility Study

Auteurs : Vaes M, Bron D, Vugts DJ, Paesmans M, Meuleman N, Ghanem G, Vanderlinden B, Thielemans K, van Dongen GA, Flamen P, Muylle K
Année : 2012
Journal : J Cancer Sci Ther
Volume : 4(12)
Pages : 394-400

Erratum to: Immune-Related Antigens, Surface Molecules and Regulatory Factors in Human-Derived Mesenchymal Stromal Cells: The Expression and Impact of Inflammatory Priming.

Auteurs : Najar M, Raicevic G, Fayyad-Kazan H, De Bruyn C, Bron D, Toungouz M, Lagneaux L
Année : 2012
Journal : Stem Cell Rev
Volume : 8(4)
Pages : 1286